Title:
シクロプロピルアミド誘導体
Document Type and Number:
Japanese Patent JP4691669
Kind Code:
B2
Abstract:
Disclosed herein is at least one cyclopropyl amide derivative of formula I, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative of formula I disclosed herein, and at least one method of using at least one cyclopropyl amide derivative of formula I disclosed herein, for treating at least one histamine H3 receptor associated condition therewith.
More Like This:
JP3719612 | UREA DERIVATIVE CONTAINING HETERO-RING |
JP2013121919 | PLASMA KALLIKREIN INHIBITOR |
WO/1988/006585 | PYRROLIDONYL ACRYLATE BLOCK POLYMERS |
Inventors:
James Arnold
Todd Andrew Brugel
Phil Edwards
Andrew Griffin
Thierry Grobrski
Dennis Labreck
Scott Throner
Stephen Vesorowski
Dean Brown
Todd Andrew Brugel
Phil Edwards
Andrew Griffin
Thierry Grobrski
Dennis Labreck
Scott Throner
Stephen Vesorowski
Dean Brown
Application Number:
JP2010521486A
Publication Date:
June 01, 2011
Filing Date:
August 20, 2008
Export Citation:
Assignee:
ASTRAZENECA AKTIEBOLAG
International Classes:
C07D207/27; C07D211/76; C07D213/56; C07D231/12; C07D233/34; C07D239/26; C07D243/08; C07D295/10; A61K31/495; A61K31/496; A61K31/506; A61K31/55; A61P3/04; A61P25/00; A61P25/02; A61P25/04; A61P25/18; A61P25/28; A61P43/00
Domestic Patent References:
JP2002534421A |
Other References:
ZHANG, X. et al,trans-1-[(2-Phenylcyclopropyl) methyl]-4-arylpiperazines: mixed dopamine D2/D4 receptor antagonists as potential antipsychotic agents,J. MED. CHEM,2000年,vol.43, no.21,p.3923-3932
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi
Noriyuki Takebayashi